Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Katangolo's Profile
Displaying 301-350 of 500 result(s).
CYDY CytoDyn Inc
11/04/2024 12:11:24 PM
An article describing the complemen (5)
CYDY CytoDyn Inc
11/01/2024 12:00:51 PM
Looking more and more likely that t (13)
CYDY CytoDyn Inc
10/30/2024 9:01:43 AM
“And a GLP-1 agonist”- talk abo (9)
CYDY CytoDyn Inc
10/26/2024 1:05:57 PM
Amazing dialogue. Lots of highlight (3)
CYDY CytoDyn Inc
10/23/2024 10:13:29 PM
I remember these studies with Alpri (2)
CYDY CytoDyn Inc
10/23/2024 6:40:09 PM
I saw a post on Reddit (sunraydoc) (31)
CYDY CytoDyn Inc
10/22/2024 7:35:15 PM
Good find. I don’t doubt you are (16)
CYDY CytoDyn Inc
10/21/2024 8:56:16 PM
Maraviroc made a splash when it fir (21)
CYDY CytoDyn Inc
10/21/2024 7:54:00 PM
Interesting find. Thank you. (4)
CYDY CytoDyn Inc
10/21/2024 7:28:34 PM
Can you please provide a link showi (2)
CYDY CytoDyn Inc
10/21/2024 1:48:30 PM
If that’s what the partnership ag (2)
CYDY CytoDyn Inc
10/21/2024 12:37:43 AM
I read your latest post over on red (26)
CYDY CytoDyn Inc
10/20/2024 1:59:06 PM
The evolutionary advantage being th (2)
CYDY CytoDyn Inc
10/20/2024 5:00:14 AM
Didn’t see that. Apologies see yo (2)
CYDY CytoDyn Inc
10/20/2024 4:58:28 AM
Thanks, MGK2 So he uses the term ne (4)
CYDY CytoDyn Inc
10/20/2024 4:36:20 AM
Your Knowledge carries this Board, (13)
CYDY CytoDyn Inc
10/20/2024 4:08:59 AM
Never said I was the sharpest tool (3)
CYDY CytoDyn Inc
10/20/2024 4:02:24 AM
Apologies, Ohm. I hadn’t consider (2)
CYDY CytoDyn Inc
10/20/2024 3:50:55 AM
I’m using your math. Yes (1)
CYDY CytoDyn Inc
10/20/2024 3:39:46 AM
Adjunct Therapy? Your List is 90+ d (3)
CYDY CytoDyn Inc
10/20/2024 3:11:50 AM
The rest of the story? I remember w (2)
CYDY CytoDyn Inc
10/20/2024 3:09:55 AM
You get it too
CYDY CytoDyn Inc
10/20/2024 1:21:19 AM
Brilliant as usual,Ohm. Your contri (2)
CYDY CytoDyn Inc
10/20/2024 1:17:55 AM
You get it. (1)
CYDY CytoDyn Inc
10/20/2024 1:15:10 AM
Haven’t watched the video, but ma
CYDY CytoDyn Inc
10/20/2024 1:10:39 AM
And to be clear, this is before the (5)
CYDY CytoDyn Inc
10/20/2024 1:02:18 AM
Neuroscientist’s (me) response he (8)
CYDY CytoDyn Inc
10/20/2024 12:53:40 AM
That’s been a question in The bac (3)
CYDY CytoDyn Inc
10/19/2024 12:12:01 PM
I remember you saying that months a (3)
CYDY CytoDyn Inc
10/17/2024 5:18:44 PM
Prospectus Supplement out https://d (4)
CYDY CytoDyn Inc
10/15/2024 4:48:28 AM
Attention Ohm: Possibly but a decre (1)
CYDY CytoDyn Inc
10/15/2024 4:36:27 AM
Yes, Sir. I saw your post the other (9)
CYDY CytoDyn Inc
10/15/2024 3:29:39 AM
Thank you, Sir. HIV has been my whe (5)
CYDY CytoDyn Inc
10/15/2024 3:24:48 AM
Sorry we were going back-and-forth (1)
CYDY CytoDyn Inc
10/15/2024 3:10:44 AM
OK, well the janssen Component make (2)
CYDY CytoDyn Inc
10/15/2024 2:58:33 AM
Excellent find and thank you for yo (5)
CYDY CytoDyn Inc
10/15/2024 2:31:19 AM
Sorry, forgot the link: https://www (1)
CYDY CytoDyn Inc
10/15/2024 2:29:15 AM
Thank you. I see connections to the (2)
CYDY CytoDyn Inc
10/15/2024 2:19:06 AM
Fostemsavir Isn’t part of the equ (1)
CYDY CytoDyn Inc
10/15/2024 2:08:07 AM
Excellent and thank you. Who owns t (1)
CYDY CytoDyn Inc
10/15/2024 2:06:18 AM
Well, fortunately, your mixup got m (6)
CYDY CytoDyn Inc
10/15/2024 1:39:15 AM
So now you have me thinking. Tradit (11)
CYDY CytoDyn Inc
10/15/2024 1:22:42 AM
Sent you a DM but what is the tie b
CYDY CytoDyn Inc
10/15/2024 1:08:36 AM
I understand your siege style analo (9)
CYDY CytoDyn Inc
10/15/2024 12:40:17 AM
I think the ideal combination will (6)
CYDY CytoDyn Inc
10/15/2024 12:19:44 AM
Another interesting note is that LL (16)
CYDY CytoDyn Inc
10/14/2024 11:58:56 PM
LL is an entry inhibitor thus not a (3)
CYDY CytoDyn Inc
10/14/2024 11:54:09 PM
I see it like you see it, but I thi (4)
CYDY CytoDyn Inc
10/14/2024 12:27:35 AM
If that proves out to be true and h (9)
CYDY CytoDyn Inc
10/08/2024 10:53:46 PM
Great Point
Go to page:
  • << First
  • < Previous
  • 6
  • 7
  • Next >

Recent Articles

  • Nabors Energy Transition Corp. II Extends Business Combination Window
  • Embassy Bancorp, Inc. Reports Growth in Financial Operations
  • Water Ways Technologies Announces Share Consolidation Plans
  • BUUU Group Limited Secures $6 Million in Successful IPO Launch
  • Collective Metals Secures CDN $262,099.98 Through Placement
  • Peyto Exploration's Monthly Dividend Announcement for Investors
  • CAPREIT Shares Exciting News About Upcoming Distribution
  • European Residential REIT Announces Important Cash Distribution
  • Associated Capital Group, Inc. Moves Forward with NYSE Delisting
  • PharmaCorp Rx Inc. Showcases Strong Growth in Q2 Financials
  • Westport Fuel Systems Advances with New Shelf Prospectus Plans
  • KinderCare Learning IPO Faces Serious Allegations and Investor Impact
  • Understanding Wynn Resorts' Stock Performance and P/E Ratio
  • The Growth Journey of Analog Devices: A 20-Year Retrospective
  • PharmaCorp Rx Inc. Shows Strong Growth in Latest Q2 Results
  • Moatable Announces Impressive Q2 2025 Financial Results
  • Moorable Inc. Shows Impressive Growth in Q2 Financial Results
  • CNFinance Adjusts ADS Ratio to Enhance Shareholder Value
  • BioSig Technologies and Streamex Successfully Close $15 Million Offering
  • How $100 Invested in Axis Capital Holdings Has Grown Over 5 Years
  • BioSig Technologies Closes Successful $15 Million Public Offering
  • QVC Group's Semi-Annual Interest Payment Details for Investors
  • Targa Exploration Plans Upsized Placement for Growth Funding
  • Cardinal Health Declares Quarterly Dividend for Shareholders
  • Investors' Chance to Join Suit Against Novo Nordisk A/S
  • FanDuel Partners with St. Louis CITY SC for Mobile Betting
  • Foresight's Transformative Steps with Upcoming Share Consolidation
  • Youxin Technology Navigates Nasdaq Compliance Challenges Ahead
  • Graphjet Technology Announces Share Consolidation Date and Details
  • Brunswick Exploration Strengthens Ownership of Mirage Project
  • Allarity Therapeutics Reports Momentum in Clinical Advancements
  • Nutex Health Faces Challenges After Report as Shares Decline
  • Brunswick Exploration Enhances Ownership at Mirage Project
  • Dollar Tree's Impressive Stock Growth Over Two Decades
  • X4 Pharmaceuticals Strengthens Leadership Team with Stock Grants
  • Transforming $100 into $246 with Valero Energy's Growth
  • Fly-E Group Faces Severe Stock Drop Amid Investigation Claims
  • Miami International Holdings Completes Successful IPO Process
  • Miami International Holdings Celebrates Share Offering Success
  • Neuberger Berman Fund Declares Monthly Distribution Announcement
  • Artis Real Estate Investment Trust Updates Monthly Cash Distribution
  • Homebuilder Stocks Surge Amid Falling Mortgage Rates This Year
  • City Office REIT Completes Transformation Through Phoenix Sale
  • Imperial Equities Inc. Updates Stock Options for Key Officer
  • David Tepper's Latest Investment Moves with Tech and Airlines
  • Investor Sentiment Surrounding Norwegian Cruise Line Stock
  • Understanding the Shift in Monster Beverage's Short Selling Trends
  • Understanding the Recent Trends of Curtiss-Wright's Stock
  • Nutex Health Inc. Engaging Investors in Fraud Investigation
  • Ebang International Holdings: Financial Growth Insights Unveiled
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site